Mirko Gabriele PhD InfiniteVision

Mirko has over 20 years of experience in the Pharma industry predominantly in Technology Transfer and Operations and he is currently consulting in this space. He has held several key roles in Technology Transfer from Project Leader to Program Manager, moving from technical feasibility assessment to complex multi-sites multi-dosages project management to overall technology transfer company portfolio management (100+ active programs). He successfully covered several dosage forms projects, from Oral to Combination products with a strong expertise in Sterile. Director/Sr Director roles in Business operations and innovation gave Mirko a full overview of the technology and pharma space. Mirko has been part of the PDA since 2005.A member of the Board of Directors since 2021, he joined and then led the writing task force which produced Technical Report 65 and he has been involved in several PDA Europe Trainings on Technology Transfer. Mirko leads the PDA Technology Transfer Interest Group (TT IG) for Europe which has the mission to define, share and implement best practices in the industry. He is currently President of the PDA Italy Chapter and CEO of InfiniteVision an emerging company with a proprietary AI-based platform applied to Pharma Innovation scouting and evaluation.